• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Laborie Medical Technologies

Laborie acquires drug-coated balloon maker Urotronic

October 27, 2023 By Sean Whooley

Laborie Medical Technologies announced today that it completed the acquisition of drug-coated balloon developer Urotronic. The companies struck an agreement last month for Laborie to buy Urotronic for up to $600 million. Urotronic developed the Optilume DCB used in interventional urology procedures. It treats urethral strictures and benign prostatic hyperplasia (BPH) or enlarged prostate conditions. […]

Filed Under: Business/Financial News, Catheters, Drug-Device Combinations, Mergers & Acquisitions, Urology Tagged With: Laborie Medical Technologies, urotronic

Laborie acquires exclusive license for drug-coated baloon treatment for urethral strictures

January 5, 2022 By Sean Whooley

Laborie Medical Technologies announced today that it acquired an exclusive license to the Optilume urethral drug-coated balloon (DCB). Portsmouth, New Hampshire-based Laborie purchased a perpetual, exclusive license to Optilume — developed by Urotronic — following FDA approval in December 2021. The DCB platform received CE mark approval for use in male anterior urethral strictures in […]

Filed Under: Business/Financial News, Catheters, Drug-Device Combinations, Featured Tagged With: Laborie Medical Technologies, urotronic

Laborie acquires Pelvalon and its device for treating fecal incontinence

October 13, 2021 By Sean Whooley

Laborie Medical Technologies announced that it acquired Pelvalon and its Eclipse non-surgical device for treating fecal incontinence. Redwood City, California-based Pelvalon designed the FDA-cleared Eclipse system as a patient-controlled device for women suffering from fecal incontinence, according to a news release. Portsmouth, New Hampshire-based Laborie was represented by Piper Sandler as financial advisor and Simpson […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Women's Health Tagged With: Laborie Medical Technologies, Pelvalon

Laborie Medical Technologies buys Clinical Innovations

December 23, 2019 By Danielle Kirsh

Laborie Medical Technologies has purchased Clinical Innovations in a deal worth $525 million. The deal is expected to close in early 2020. Through the deal, Clinical Innovations will continue to help mothers and babies through its labor, delivery and neonatal intensive care specialties. “This is a promising deal that will add scale to the overall […]

Filed Under: Mergers & Acquisitions Tagged With: Clinical Innovations, Laborie Medical Technologies

Laborie Medical closes $214m Cogentix buy

April 23, 2018 By Brad Perriello

Laborie Medical Technologies said today that it closed the $214 million acquisition of Cogentix Medical (NSDQ:CGNT). With about 85% of the urology and gynecology device maker’s shares tendered over the weekend, meeting the minimum tender requirement, the stage was set for the deal to close today. The $3.85-per-share cash tender pulled in some 51.5 million shares, for about $198.2 million, […]

Filed Under: Mergers & Acquisitions, Urology, Women's Health Tagged With: Cogentix Medical, Laborie Medical Technologies

Laborie Medical to pay $214m for Cogentix

March 12, 2018 By Brad Perriello

Laborie Medical Technologies said today that it agreed to pay $214 million for Cogentix Medical (NSDQ:CGNT) and its line of urology and gynecology devices. Formed by the 2015 merger of Vision-Sciences and Uroplasty, Minnetonka, Minn.-based Cogentix makes the Urgent PC neuromodulation device for treating overactive bladder syndrome, the PrsimeSight cystoscopy and EndoSheath devices and Macroplastique, an injectable soft-tissue bulking agent for […]

Filed Under: Mergers & Acquisitions, Urology, Wall Street Beat, Women's Health Tagged With: Cogentix Medical, Laborie Medical Technologies

Audax deals Laborie Medical to Patricia Industries

September 19, 2016 By Fink Densford

Private equity player Audax Group said today it sold Laborie Medical Technologies to Investor AB subsidiary Patricia Industries for an undisclosed amount. Toronto-based Laborie Medical Tech develops and manufactures urological, pelvic health and gastrointestinal medical devices used for diagnosis and treatment of urinary incontinence and other urological and GI conditions, Audax Medical said. Laborie acquired the pelvic muscle […]

Filed Under: Mergers & Acquisitions, Urology, Wall Street Beat Tagged With: Audax Group, Laborie Medical Technologies

Medi-Tate wins strategic investment from Canada’s Laborie Medical Technologies

July 7, 2016 By Brad Perriello

Laborie Medical Technologies said it took out a stake in Israel’s Medi-Tate, which is developing devices to treat enlarged prostates, for an unspecified amount. Toronto-based Laborie, which is owned by private equity company Audax Group, in October 2013 acquired the pelvic muscle rehabilitation business of UroMed Technology, also for an undisclosed amount. Akiva, Israel-based Medi-Tate developed a minimally invasive […]

Filed Under: Funding Roundup, Urology, Wall Street Beat Tagged With: Laborie Medical Technologies, Medi-tate Ltd.

Laborie Medical buys UroMed’s pelvic rehab biz

October 9, 2013 By Brad Perriello

Laborie Medical buys UroMed's pelvic rehab biz
Laborie Medical buys UroMed's pelvic rehab biz

Laborie Medical Technologies said it acquired the pelvic muscle rehabilitation business of UroMed Technology for an undisclosed amount.

Toronto-based Laborie, which is owned by private equity company Audax Group, said the UroMed business expands its offering in the pelvic muscle rehab and conservative therapy space.

Filed Under: Gynecological, Mergers & Acquisitions, News Well, Urology Tagged With: Audax Group, Laborie Medical Technologies, UroMed Technology, Venture Capital/Private Equity

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy